• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ORTHO-CLINICAL DIAGNOSTICS VITROS IMMUNODIAGNOSTIC PRODUCTS ANTI-SARS-COV-2 IGG REAGENT PACK; IN-VITRO DIAGNOSTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ORTHO-CLINICAL DIAGNOSTICS VITROS IMMUNODIAGNOSTIC PRODUCTS ANTI-SARS-COV-2 IGG REAGENT PACK; IN-VITRO DIAGNOSTIC Back to Search Results
Catalog Number 6199919
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 02/13/2021
Event Type  malfunction  
Manufacturer Narrative
The investigation determined that a discordant, reactive vitros anti- sars-cov-2 igg (cov2igg) result was obtained from a single patient sample processed using vitros cov2igg reagent lot 0280 on a vitros xt 7600 integrated system.The vitros cov2igg result was discordant when compared to a non-reactive vitros anti- sars-cov-2 total (cov2tot) result from the same patient sample.A definitive assignable cause for the event was not established.Based on historical qc results, a vitros cov2igg reagent performance issue is not a likely contributor to the event as qc fluid results were within the correct ifu interpretation region leading up to the event.Additionally, ongoing tracking and trending of complaints has not identified any signals that would point to a potential systemic issue with vitros cov2igg lot 0280.An instrument issue cannot be ruled out as a contributor to the event, as no diagnostic precision testing was conducted to verify the performance of the vitros xt7600 integrated system.It was not possible to establish whether the customer was following the sample collection device manufacture¿s recommendation for sample centrifugation.Improper pre-analytical sample handling could have contributed to this event.It is possible that cellular debris, due to poor sample preparation, was present in the affected sample, although this could not be confirmed.Interference from a non-specific antibody cannot be ruled out as a contributor to the event, as no testing to rule out an interferent was not conducted on the sample from the patient when requested.It is possible that an interferent that affected the vitros cov2igg reagent assay and not the vitros cov2tot reagent assay contributed to the event, but this could not be confirmed.A definitive assignable cause of the event was not determined.(b)(4).
 
Event Description
A customer obtained a discordant, reactive vitros anti- sars-cov-2 igg (cov2igg) result from a single patient sample processed using vitros cov2igg reagent lot 0280 on a vitros xt 7600 integrated system.The vitros cov2igg result was discordant when compared to a non-reactive vitros anti- sars-cov-2 total (cov2tot) result from the same patient sample.Patient 1, vitros cov2igg result of 1.28 s/c (reactive) versus the vitros cov2tot result of 0.36 s/c (non-reactive).Biased results of the direction and magnitude observed may lead to inappropriate physician action if undetected.The reactive vitros cov2igg result was not reported from the laboratory.Ortho has not been made aware any allegation of actual patient harm as a result of this event.This report corresponds to ortho clinical diagnostics inc (ortho).Complaint number (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VITROS IMMUNODIAGNOSTIC PRODUCTS ANTI-SARS-COV-2 IGG REAGENT PACK
Type of Device
IN-VITRO DIAGNOSTIC
Manufacturer (Section D)
ORTHO-CLINICAL DIAGNOSTICS
100 indigo creek drive
rochester NY 14626
Manufacturer (Section G)
ORTHO CLINICAL DIAGNOSTICS
felindre meadows
pencoed
bridgend, wales CF35 5PZ
UK   CF35 5PZ
Manufacturer Contact
laurie o'riordan
100 indigo creek drive
rochester, NY 14626
5854533000
MDR Report Key11448698
MDR Text Key240786552
Report Number3007111389-2021-00033
Device Sequence Number1
Product Code QKO
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Other
Type of Report Initial
Report Date 03/09/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/09/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/28/2021
Device Catalogue Number6199919
Device Lot Number0280
Was Device Available for Evaluation? Yes
Date Manufacturer Received02/13/2021
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured10/22/2020
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
-
-